BioConnection receives European CMO of the year award 2024 in biopharmaceuticals
Oss, the Netherlands, 8 October 2024 — BioConnection is excited to announce that they have received the European Company of the Year 2024 award in biopharmaceutical contract manufacturing from Pharma Tech Outlook.
This recognition reflects the trust BioConnection has earned from its customers and peers in the biopharmaceutical industry. Being acknowledged by a panel of C-level executives, industry experts, and the editorial team of Pharma Tech Outlook is a great honor. It highlights the dedication and hard work of the entire BioConnection team in delivering top-quality contract manufacturing services.
BioConnection remains passionate about supporting its clients in bringing innovative therapies to market. This award motivates the company to continue making a positive impact in the biopharmaceutical sector.
You can find the full press release here.
Find more news here.